From BioHealth Investor The following list represents the top ten medical stocks ranked according to Earnings Per Share and Relative Strength by Investor’s Business Daily (3/03/06) scores out of 100 (last week’s rank, change…
by H.S. AyoubBioHealth Investor.com Thermogenesis (KOOL) announced early Friday that the company has increased its manufacturing capacity for the cord blood stem cell disposable bags for use with the AutoXpress system. The company can…
There has been another diabetes treatment-seeker that has filed to come public. Sirtris Pharmaceuticals has filed for an IPO and it has enlisted JPMorgan, CIBC, Piper Jaffray, JMP Securities, and Rodman & Renshaw as…
By William Trent, CFA of Stock Market Beat Large Cap Watch List member Barr Pharmaceuticals (BRL) reported a GAAP Loss: For the three months ended December 31, 2006, the Company recorded a loss of…
A Canadian biotech company named Endoceutics, Inc. has filed with the SEC to raise up to $75 million via an IPO. The underwriting group is listed as First Albany, Oppenheimer, and Stifel Nicolaus. Endoceutics…
by Aaron F. Barkoff We reported last month on a new declaratory judgment action that Apotex filed against GlaxoSmithKline (GSK) in the Eastern District of Virginia. In its complaint, Apotex alleged that Glaxo’s listing…
From BioHealth Investor On the front page of the Tuesday edition of Investors Business Daily, Reinhardt Krause wrote a great article on the expansion of the biotechnology boom around the U.S. California and Boston,…
Biotech Implosion: Threshold Pharmaceuticals (THLD) Threshold Pharmaceuticals, Inc. (THLD-NASDAQ) came clean after the close and announced that a Phase 3 trial of glufosfamide did not show a statistically significant improvement in overall survival in…
Boston Scientific (BSX) investors cringe every time a new study comes on about the long-term health hazards of stents. The drum beat has helped drop the share price from over $33 two years ago…
From BioHealth Investor The following articles were the most popular at BioHealth Investor for the week of February 17 – February 23. 1. Novadel Drops After Zensana Launch Delayed by Hana Biosciences 2. Acorda…